🦊/Investors

Archangels

Angel networkInactive

Edinburgh · Pre-Seed–Series A · 14 people tracked

This fund appears to be inactive.

UK Companies House records show ARCHANGELS LIMITED (no. 06879445) as dissolved. It is unlikely to be making new investments — this profile is kept for reference and historical accuracy.

Find your way into Archangels

2,866 people in our graph share verified history with the Archangels team — schools, employers, funds. One of them is your warm intro.

David Phuunlockedknows Dan McKiddie · together at PwC (overlapped)
×6knows the team · via PwC
knows the team · via Harvard University
knows the team · via Lloyds Bank
knows the team · via MIT Sloan School of Management
×2knows the team · via KPMG
Fox Verdict
Sign up to see your fit

Investment thesis

Archangels connects its members with carefully selected early-stage investment opportunities in Scotland's most innovative companies, aiming to deliver strong returns while supporting entrepreneurs through their early development. It leverages the experience and networks of its members to help build successful Scottish businesses, focusing on the technology and life sciences sectors. Members are motivated both by financial returns and by contributing to the growth of the Scottish entrepreneurial ecosystem.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Series A
HQ
Edinburgh, GB
Instruments
Equity
Founded
1992
Last 12 months
1 investment
Tracked investments
49

Team · 14 people

from the firm's website & public directories
Eric Young· Investor

What they invest in

from 18 of 49 portfolio companies

AI & Machine Learning ×8Deep Tech ×5Healthtech ×5Medical Devices ×5Biotech ×4Enterprise Software ×4Hardware ×4Data & Infrastructure ×3

HQs:United Kingdom×9

Investments · 49 tracked

founders shown can be your intro path

By year:2026 · 12025 · 22024 · 22023 · 42022 · 22021 · 22019 · 12018 · 22017 · 117 dated

NCTechnctechimaging.comin𝕏✓ verified

NCTech provides high-resolution 360° imagery and geospatial data insights to government, utility, telecommunications, and technology companies globally.

AI & Machine LearningData & InfrastructureEnterprise SoftwareGovTechPropTechUK, GB

Co-investorsBritish Business BankScottish Enterprise

1nhaler1nhaler.comNov 2023

1nhaler develops a single-dose dry powder inhaler made mostly from cardboard, designed to be low-cost, portable, propellant-free and low in carbon impact for delivering inhalable medicines.

HealthtechMedical DevicesNew Materials

Helen Muirhead(Chief Scientific Officer)Lars Larsson(Chief Medical Officer)

Biolibertybioliberty.cominSeed · Apr 2023 · $3M

Bioliberty develops the Lifehub Clinic system, combining soft robotic wearables, gamified therapy, and AI insights to help clinicians deliver physical and occupational therapy to patients recovering from mobility issues such as stroke.

Digital HealthMedical DevicesRoboticsEdinburgh, GB

Rowan Armstrong(Founder)inShea Quinn(Founder)in

Co-investorsBallad VenturesScottish National Investment Bank

Calciviscalcivis.cominApr 2024 · $1M

CALCIVIS develops the CALCIVIS Imaging System, a chairside diagnostic device that provides real-time assessment of enamel demineralization and tooth decay activity to support preventive dentistry.

BiotechDigital HealthHealthtechMedical DevicesEdinburgh, GB

Gregory M. Sheehan(CEO)inJill McGregor(COO)inBruce Vernon(Co-founder & CTO)Peter Anthony Rees(Director)Adam Christie(Co-founder & CEO)James Jonathan Browning(Director)

Co-investorsScottish National Investment BankBritish Business BankMaven Capital PartnersScottish EnterpriseScottish Investment Bank

CSignumcsignum.cominApr 2025

CSignum develops electromagnetic field-based communication and sensing solutions for underwater, underground, and IoT applications.

Deep TechEnergyIoT

Jonathan(CEO)

Co-investorsBessemer Venture PartnersRaptor GroupDeep FutureScottish Enterprise

Cytomoscytomos.comin𝕏Seed · Jun 2022 · $2M

Cytomos develops AuraCyt®, a microelectronics-based biotechnology platform for real-time single-cell analytics in bioprocessing and cell and gene therapy manufacturing.

BiotechDeep TechMedical Devices

Co-investorsBritish Business BankOld College CapitalScottish Enterprise

Earth Bloxearthblox.ioin𝕏Seed · Mar 2026 · $2M

Earth Blox provides a platform that translates nature and climate data into financial insights for organizations to manage environmental risks, allocate capital, and identify investment opportunities.

AI & Machine LearningClimate TechData & InfrastructureEnterprise SoftwareFintechGovTech

Sam Fleming(Founder)in

Co-investorsScottish Enterprise

Fios Genomicsfiosgenomics.comin𝕏

Fios Genomics provides bioinformatics data analysis services for drug discovery, development, and applied research to biotechnology and pharmaceutical companies, contract research organizations, and academic institutions.

AI & Machine LearningBiotechData & InfrastructureEdinburgh, GB

Prof. Peter Ghazal(Founder)

Flexitricityflexitricity.comin

Flexitricity operates in the flexible energy market in Great Britain, connecting participants to revenue-generating opportunities in demand-side energy flexibility.

AI & Machine LearningCleantechClimate TechEnergyEnterprise SoftwareEdinburgh, GB

Co-investorsDrax Group

iGiiigii.ukSeed · Dec 2024 · $4M

iGii develops and manufactures Gii, a proprietary 3D porous pure carbon material for high-performance sensing, heating, and energy technologies.

Advanced ManufacturingCleantechDeep TechEnergyHardwareNew MaterialsScotland, GB

Dr. Marco Caffio(Co-founder & CSO)Jean-Christophe Granier(CEO & CCO)in

Co-investorsScottish National Investment Bank

MGB Biopharmamgb-biopharma.comin𝕏

MGB Biopharma is a biopharmaceutical company focused on drug development, with expertise spanning clinical practice, medical science, and the transition from preclinical to clinical development for biologics and small molecules.

Biotech

Dr Miroslav Ravic(Chief Executive Officer, Chief Science Officer & Chief Medical Officer)Raymond Spencer(Chief Financial Officer)Chris Wardhaugh(Chief Business Officer)

Co-investorsArchangelInnovate UKScottish Investment Bank

Neuranicsneuranics.comin𝕏Seed · Apr 2025 · $8M

Neuranics develops magnetic sensing solutions using TMR (Tunneling Magnetoresistance) technology for XR hardware, wearable devices, and digital health applications.

AI & Machine LearningDeep TechHardwareHealthtechSemiconductors

Kia Nazarpour(Chief Strategy Officer & Co-Founder)Hadi Heidari(Chief Technology Officer & Co-Founder)Siming Zuo(Innovation Manager & Co-Founder)

Co-investorsBlackfinch Ventures

Optosoptos.comin𝕏

Optos develops ultra-widefield retinal imaging devices for eyecare professionals to detect, diagnose, document, and treat ocular pathology.

HardwareHealthtechMedical Devices

Douglas Anderson

Co-investorsAmadeus Capital Partners

Powerphotonicpowerphotonic.comMay 2018

PowerPhotonic designs and manufactures wafer-scale freeform optics, including beam shapers, diffusers, homogenizers, and combiner optics, for engineers building advanced laser systems.

Advanced ManufacturingDeep TechHardwareFife

BoardSimon Clovis Younger(Director)

Co-investorsMaven Capital Partners

QueryClickqueryclick.comin𝕏Aug 2019 · $2M

QueryClick is a UK-based independent digital marketing agency offering full-service search optimisation, including technical SEO, paid media, and AI/answer-engine optimisation.

AdTechAI & Machine LearningMarketing Tech

Chris Liversidge(Founder)in

Co-investorsScottish Investment Bank

Restokerestoke.aiin𝕏

Restoke provides restaurant management software that helps restaurant owners focus on food quality and operations by automating administrative tasks and reducing waste.

AI & Machine LearningEnterprise SoftwareFoodTechFuture of WorkSaaS

Ken Brand(Founder)in

Co-investorsArchangel VenturesMandalay Venture PartnersRampersandStage 2 CapitalSkalata

Speech Graphicsspeech-graphics.com

Speech Graphics develops audio-driven facial animation technology that converts speech and audio into lip sync and facial expressions.

AI & Machine LearningGamingMedia & Entertainment

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

1inhalerAdministrateArrayjetBDDBead BiopharmaBio-Images Drug DeliveryBioCaptivaBlackford AnalysisBloxxCritiqomCrombie AndersonCXR biosciencesGBGHearing DiagnosticsIndigo LighthouseIntegrated Graphene IgiiLabMpathyObjective Software Technology LtdOptoscribeOregon Timber FramePhysioWizardReactecSentient MedicalSolCom SystemsStem Cell SciencesThairm BioTissue Science LaboratoriesTouch BionicsTrigVitrologyZonefox

Portfolio news

latest coverage across their companies

Principals & officers · per Companies House

what is this? ⓘ
Bibi Rahima Ally

Secretary · British · since 2009

Jerome Feldman

Director · French · since 2009

Laurent Maarek

Director · French · since 2009

Joseph-Alain Ruimy

Director · French · since 2011

Frequently asked questions

How many investments has Archangels made?
Archangels has 49 tracked investments, including 4 dated in the last 24 months.
What stage does Archangels invest at?
Archangels invests at the Pre-Seed, Seed, Series A stages.
What sectors does Archangels focus on?
Archangels focuses on Biotech, Deep Tech, Healthtech, Sector Agnostic.
Where is Archangels located?
Archangels is headquartered in Edinburgh, GB.
Who does Archangels co-invest with?
Archangels most often shares deals with Scottish National Investment Bank, Amadeus Capital Partners, Blackfinch Ventures, among 7 tracked co-investors.

Media · Podcasts & interviews

from their channel

Archangels - Celebrating 30 Years Investing in Innovation

Archangel Investors Ltd

Archangels Film | Quarter Century Anniversary

Archangel Investors Ltd

Archangels | Company Portfolio | 2015 Various

Archangel Investors Ltd

Images

Archangels photoArchangels photoArchangels photoArchangels photo

Co-investors · 1

Techstart Ventures

Techstart Ventures is an early-stage investor backing companies from inception to pre-seed in Scotland and Northern Ireland.

$950K

Firms observed investing alongside Archangels, from public investor directories. Shared companies are the overlap with Archangels's recorded portfolio.

Similar investors